FDA Grants AP Status for Lurasidone Hydrochloride ANDA208055
The FDA has granted approval status (AP) for the ANDA208055 application for Lurasidone Hydrochloride submitted by Torrent.
Company
Torrent Pharmaceuticals
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The FDA's approval of Torrent's ANDA208055 for Lurasidone Hydrochloride presents a significant competitive challenge in the antipsychotic market. This could lead to pricing pressures and shifts in market share among established players, necessitating strategic reassessment.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor the timeline for market launch and any subsequent competitive responses from established antipsychotic manufacturers.
Related companies & assets
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.